The largest database of trusted experimental protocols

2 fucosyllactose

Manufactured by Merck Group
Sourced in Germany

2'-Fucosyllactose is a prebiotic oligosaccharide derived from human milk. It is a component of human milk oligosaccharides (HMOs), which are complex carbohydrates found in breast milk. 2'-Fucosyllactose is the most abundant HMO in human milk and plays a role in the development and maturation of the infant gut microbiome.

Automatically generated - may contain errors

2 protocols using 2 fucosyllactose

1

Bifidobacterium Carbohydrate Utilization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Bifidobacterium strains were routinely cultured at 37 °C in Wilkins-Chalgren Anaerobe Broth (Oxoid, Basel, Switzerland) supplemented with soya peptone (5 g L−1, Oxoid), Tween 80 (1 mL L−1, Sigma-Aldrich, Buchs, Switzerland), and fresh sterile filtered l-cysteine hydrochloride (0.5 g L−1, Sigma-Aldrich). Carbohydrate utilization profile of bifidobacteria was investigated in API 50CHL Medium (10 g L−1 bovine/porcine origin polypeptone, 5 g L−1 yeast extract, 1 mL−1 Tween 80, 2 g L−1 dipotassium phosphate, 5 g L−1 sodium acetate, 2 g L−1 di-ammonium citrate, 0.2 g L−1 magnesium sulphate heptahydrate, 0.05 g L−1 manganese sulphate monohydrate, 0.17 g L−1 bromocresol purple; BioMérieux, Genève, Switzerland). The pH of the API medium was adjusted to 7.5 to obtain a final pH of 7 after autoclaving at 121 °C for 15 min. Carbohydrates (concentration as indicated) were filter sterilized and added after autoclaving. Fresh sterile filtered l-cysteine hydrochloride was always added before cultivation (0.5 g L−1). Glucose, lactose, and L-fucose were obtained from Sigma-Aldrich, 2′-fucosyllactose (2′-FL, Fucα1-2Galβ1-4Glc), 3′-fucosyllactose (3′-FL, Fucα1-3Galβ1-4Glc), 3′-sialyl-lactose (3′-SL, NeuAcα2-3Galβ1-4Glc), 6′-sialyl-lactose (6′-SL, NeuAcα2-6Galβ1-4Glc), Lacto-N-neotetraose LNnT (Galβ1-4GlcNacβ1-3Galβ1-4Glc) were donated by Glycom A/S (Lyngby, Denmark).
+ Open protocol
+ Expand
2

Oral Treatment of C. jejuni Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treatment through oral administration via drinking water of carvacrol, deferoxamine, deoxycholic acid (all from Sigma-Aldrich, Munich, Germany), 2′-fucosyl-lactose (Chr. Hansen HMO GmbH, Rheinbreitbach, Germany), and the quadruple combination commenced 2 days following the onset of C. jejuni infection. Dosages were calculated considering an average body weight of approximately 25 g per mouse and an estimated drinking volume of 5 mL per day. All compounds were dissolved in autoclaved tap water. The daily doses and their previously determined minimal inhibitory concentrations (MICs) are illustrated in Table 1. To enhance the water solubility of carvacrol, 50 mg of the compound were dissolved in 250 μL Tween® 80 (Sigma-Aldrich, Munich, Germany). The placebo group received vehicle dissolved in autoclaved tap water.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!